| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $49,419,525 | 12 | 100 |
| RA CAPITAL MANAGEMENT, L.P. | 0 | $0 | 12 | $49.42M | $-49.42M |
Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is their engineered absence of the CD33 protein, which is commonly found on AML blood cancer cells. The company's eHSC platform is …
Over the last 12 months, insiders at Vor Biopharma Inc. have bought $0 and sold $49.42M worth of Vor Biopharma Inc. stock.
On average, over the past 5 years, insiders at Vor Biopharma Inc. have bought $38.75M and sold $30.73M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 38,974,101 shares for transaction amount of $38.75M was made by Reprogrammed Interchange LLC (10 percent owner) on 2024‑12‑30.
| 2026-07-16 | Sale | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 213 0.0035% | $19.75 | $4,207 | +20.59% | |
| 2026-04-22 | Sale | RA CAPITAL MANAGEMENT, L.P. | 165,150 2.4804% | $15.77 | $2.6M | +22.58% | ||
| 2026-04-20 | Sale | RA CAPITAL MANAGEMENT, L.P. | 171,963 2.5186% | $15.77 | $2.71M | +19.35% | ||
| 2026-04-17 | Sale | RA CAPITAL MANAGEMENT, L.P. | 458,411 6.5633% | $16.28 | $7.46M | +12.84% | ||
| 2026-04-15 | Sale | RA CAPITAL MANAGEMENT, L.P. | 53,644 0.8032% | $16.01 | $858,840 | +19.52% | ||
| 2026-04-14 | Sale | RA CAPITAL MANAGEMENT, L.P. | 153,735 2.2962% | $15.97 | $2.46M | +17.20% | ||
| 2026-04-13 | Sale | RA CAPITAL MANAGEMENT, L.P. | 530,610 8.0147% | $16.15 | $8.57M | +16.41% | ||
| 2026-04-10 | Sale | RA CAPITAL MANAGEMENT, L.P. | 828 0.0122% | $15.75 | $13,041 | +20.10% | ||
| 2026-04-09 | Sale | RA CAPITAL MANAGEMENT, L.P. | 135,201 1.9422% | $16.59 | $2.24M | +18.91% | ||
| 2026-04-08 | Sale | RA CAPITAL MANAGEMENT, L.P. | 484,104 6.9079% | $16.48 | $7.98M | +17.59% | ||
| 2026-04-06 | Sale | RA CAPITAL MANAGEMENT, L.P. | 589,257 8.7684% | $16.59 | $9.78M | +13.71% | ||
| 2026-04-02 | Sale | RA CAPITAL MANAGEMENT, L.P. | 260,000 3.9778% | $18.23 | $4.74M | +2.33% | ||
| 2025-10-30 | Sale | RA CAPITAL MANAGEMENT, L.P. | 24,579 0.3511% | $25.12 | $617,424 | -37.92% | ||
| 2025-10-29 | Sale | RA CAPITAL MANAGEMENT, L.P. | 251,518 3.6075% | $25.22 | $6.34M | -39.14% | ||
| 2025-10-28 | Sale | RA CAPITAL MANAGEMENT, L.P. | 124,311 1.9383% | $27.42 | $3.41M | -42.37% | ||
| 2025-10-27 | Sale | RA CAPITAL MANAGEMENT, L.P. | 90,941 1.4543% | $28.12 | $2.56M | -44.83% | ||
| 2025-10-24 | Sale | RA CAPITAL MANAGEMENT, L.P. | 53,345 0.8498% | $28.01 | $1.49M | -42.92% | ||
| 2025-10-23 | Sale | RA CAPITAL MANAGEMENT, L.P. | 76,880 1.2247% | $28.01 | $2.15M | -44.09% | ||
| 2025-10-21 | Sale | RA CAPITAL MANAGEMENT, L.P. | 25,027 0.3999% | $28.11 | $703,509 | -44.11% | ||
| 2025-10-21 | Sale | Reprogrammed Interchange LLC | 10 percent owner | 200 0.0034% | $30.07 | $6,015 | -44.11% |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 4501882 8.3082% | $89.41M | 1 | 24 | <0.0001% |
| PARMAR KUSH | 1766634 3.2603% | $35.09M | 1 | 1 | <0.0001% | |
| 5AM Ventures VI, L.P. | 10 percent owner | 1766634 3.2603% | $35.09M | 1 | 1 | <0.0001% |
| Reprogrammed Interchange LLC | 10 percent owner | 1166909 2.1535% | $23.17M | 1 | 30 | <0.0001% |
$831,902,292 | 108 | 9.34% | $1.2B | |
$15,410,062 | 81 | 39.69% | $975.93M | |
$11,663,618 | 57 | 32.20% | $934.29M | |
$276,808,393 | 17 | -6.69% | $888.11M | |
$24,007,605 | 16 | -20.65% | $1.33B |
| Increased Positions | 46 | +153.33% | 22M | +585.13% |
| Decreased Positions | 12 | -40% | 258,682 | -6.87% |
| New Positions | 27 | New | 9M | New |
| Sold Out Positions | 10 | Sold Out | 248,540 | Sold Out |
| Total Postitions | 64 | +113.33% | 26M | +578.26% |
| Ra Capital Management, L.P. | $23,074.00 | 9.01% | 1.98M | <1 | 0% | 2025-09-30 |
| Vr Adviser, Llc | $5,820.00 | 2.27% | 499,966 | +499,966 | New | 2025-09-30 |
| Fcpm Iii Services B.V. | $4,419.00 | 1.73% | 379,640 | +379,640 | New | 2025-09-30 |
| Fmr Llc | $2,753.00 | 1.08% | 236,508 | +131,874 | +126.03% | 2025-09-30 |
| Ariose Capital Management Ltd | $1,282.00 | 0.5% | 110,173 | +110,173 | New | 2025-09-30 |
| Vanguard Group Inc | $1,224.00 | 0.48% | 105,190 | +9,410 | +9.82% | 2025-09-30 |
| Ubs Group Ag | $884.00 | 0.35% | 75,909 | -673 | -0.88% | 2025-09-30 |
| Johnson & Johnson | $625.00 | 0.24% | 53,732 | <1 | <0.01% | 2025-09-30 |
| Tang Capital Management Llc | $582.00 | 0.23% | 50,000 | +50,000 | New | 2025-09-30 |
| Blackrock, Inc. | $402.00 | 0.16% | 34,530 | +15,792 | +84.28% | 2025-09-30 |